Jake Heinrichs hugs his wife, Rachel Chavkin, after speaking about early-stage Alzheimer's disease while inside their home in ...
In a major Phase 3 clinical trial, lecanemab showed it could slow the decline in memory and thinking ability by 27% overall ...
An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in ...
CervoMed's stock soars 400% on promising dementia drug data. See more on insights, potential concerns, and what it means for ...
Leqembi is an infusion therapy that targets and removes the beta-amyloid plaque that builds up in the brains of Alzheimer's ...
While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...
An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in their 40s or 50s, according to new findings from ongoing research now caught ...
The new findings center on a subset of 22 participants who received amyloid-removing drugs the longest, on average eight ...
Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback